Medication info

Shinil Tramadol Hydrochloride Injection

Prescription medicationInjectionsIntramuscular injection · Intravenous injectionApproval withdrawn
Ingredient · strength
Tramadol Hydrochloride›50mg / 1mL
Manufacturer / importer
Shinil Pharmaceutical Co., Ltd.
Appearance
A brown ampoule filled with a colorless transparent liquid for injection
Packaging
1 milliliter/ampoule X 50
Approval status
Approval withdrawn

MFDS item code 199602177 · Notified 1996.07.09

This product's status changed to Approval withdrawn on 2026.01.14. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Relief of pain after diagnostic procedures or surgery and moderate to severe acute or chronic pain (e.g., cancer pain)
Who receives it
Adults
Adult administration
The dose of this drug should be adjusted according to the patient's pain intensity and clinical response. In general, use the lowest dose that relieves the pain. Adults After administering 50-100mg of tramadol hydrochloride by intravenous or intramuscular injection, repeat the injection every 4-5 hours as needed. Up to 400mg per day may be administered. Elderly No dose adjustment is necessary for patients 75 years of age or younger in whom hepatic or renal impairment has not been clinically identified. Since excretion of this drug may be delayed in patients over 75 years of age, adjust the dosing interval as needed. Patients with renal impairment/on dialysis or hepatic impairment Since excretion of this drug may be delayed in patients with renal or hepatic impairment, consider extending the dosing interval in these patients.

Ingredients

Manufacturer
Shinil Pharmaceutical Co., Ltd.

Efficacy & effects

Relief of pain after diagnostic procedures or surgery and moderate to severe acute or chronic pain (e.g., cancer pain)

  • Severe pain
  • moderate pain
  • acute chronic pain
  • various cancer pain
  • post-diagnostic pain
  • post-surgical pain
View approved original text

This medication is used for the relief of severe and moderate acute chronic pain, for example, pain caused by various cancers or pain after diagnostic procedures and surgery.

How it is given

Adult administration

The dose of this drug should be adjusted according to the patient's pain intensity and clinical response. In general, use the lowest dose that relieves the pain. Adults After administering 50-100mg of tramadol hydrochloride by intravenous or intramuscular injection, repeat the injection every 4-5 hours as needed. Up to 400mg per day may be administered. Elderly No dose adjustment is necessary for patients 75 years of age or younger in whom hepatic or renal impairment has not been clinically identified. Since excretion of this drug may be delayed in patients over 75 years of age, adjust the dosing interval as needed. Patients with renal impairment/on dialysis or hepatic impairment Since excretion of this drug may be delayed in patients with renal or hepatic impairment, consider extending the dosing interval in these patients.

Precautions

Caution should be exercised as seizures may occur if the recommended dose is exceeded. In particular, it should only be used in patients with epilepsy or a risk of seizures when absolutely necessary. Long-term use may lead to psychological and physical dependence, so it should only be administered for a short duration under strict supervision in patients with a history of drug abuse or dependence. Using this drug with alcohol or central nervous system depressants may lead to severe sedation, respiratory depression, coma, or even death, so combinations should be avoided or used with extreme caution. Patients with the CYP2D6 ultra-rapid metabolizer genotype may metabolize the active ingredient of this drug more quickly, increasing the risk of respiratory depression; therefore, dosage adjustment and monitoring may be required. This drug should not be administered to children under 12 years old or certain patients under the age of 18 who have undergone specific surgeries, and adolescents over 12 should also avoid it if there are risk factors. It should not be administered to patients with acute alcohol intoxication, central nervous system drug overdose, severe respiratory depression, head injury, or those taking MAO inhibitors. Patients with severely impaired liver or kidney function, pregnant or nursing women, or those with hypersensitivity to opioid medications should also not use this medication. While using this drug, drowsiness, dizziness, and other side effects may occur, so driving or operating hazardous machinery should be avoided. Long-term use may lead to tolerance and increased dosages, and sudden discontinuation may cause withdrawal symptoms; therefore, gradual dose reduction is recommended. This drug may interact with various medications, so patients taking other medications should consult healthcare professionals. In cases of overdose, severe respiratory depression and seizures may occur, requiring emergency treatment. When storing, keep it out of reach of children and store in its original container for safety.

Side effects

  • cramps
  • seizures
  • hypersensitivity
  • shock
  • anaphylaxis
  • itching
  • urticaria
  • bronchospasm
  • angioedema
  • respiratory depression
Show 74 more
  • dyspnea
  • asthma exacerbation
  • hiccups
  • palpitations
  • coldness
  • mimicry concerns
  • vasodilation
  • hypotension
  • arrhythmia
  • facial pallor
  • syncope
  • orthostatic hypotension
  • tachycardia
  • bradycardia
  • hypertension
  • drowsiness
  • sleep
  • headache
  • heaviness in the head
  • agitation
  • tremors
  • tinnitus
  • numbness in both hands
  • anxiety
  • fatigue
  • weariness
  • sweating
  • dizziness
  • unsteadiness
  • discomfort
  • dysuria
  • xerostomia
  • thirst
  • confusion
  • cooperation disturbance
  • hyperesthesia
  • restlessness
  • sleep disturbance
  • cognitive impairment
  • hallucinations
  • amnesia
  • concentration difficulties
  • depression
  • changes in appetite
  • sensory abnormalities
  • epileptiform seizures
  • involuntary muscle contractions
  • muscle weakness
  • hypertonia
  • urinary retention
  • frequency of urination
  • menopause syndrome
  • urinary disorders
  • menstrual disorders
  • Stevens-Johnson syndrome
  • skin reactions
  • sweating
  • allergic reactions
  • fever
  • warmth
  • chills
  • coolness
  • visual disturbances
  • taste disturbances
  • weight loss
  • irritation at the injection site
  • agitation
  • anxiety
  • nervous sensitivity
  • insomnia
  • excessive exercise
  • panic attacks
  • severe anxiety
  • sensory abnormalities

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container that blocks light and prevents air entry. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius to safely preserve the drug's effectiveness.

Appearance and packaging

Appearance

A brown ampoule filled with a colorless transparent liquid for injection

Package unit

1 milliliter/ampoule X 50

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.